{"product_id":"pck2-antibody-sc-f1007","title":"PCK2 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003ePhosphoenolpyruvate carboxykinase (PEPCK), a key enzyme in gluconeogenesis, catalyzes the GTP-dependent conversion of oxaloacetate (OAA) to the glycolytic intermediate phosphoenolpyruvate (PEP). The enzyme has two isoforms: the cytoplasmic PCK1 (PEPCK-C) and the mitochondrial PCK2 (PEPCK-M). PCK2 is expressed in various cancers, including lung, breast, and prostate cancer, as well as in non-neoplastic tissues, including the lung.\u003c\/p\u003e\u003cp\u003eReported cellular context includes mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following PCK2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003ePCK2 is commonly interpreted in the context of metabolism and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans mitochondrion, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003esignal enrichment within mitochondrion relative to the broader cellular background\u003c\/li\u003e\n\u003cli\u003eresponses linked to nutrient status, mitochondrial state, or metabolic rewiring\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for PCK2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in PCK2 reflect biology rather than handling. When interpreting PCK2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep PCK2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577588195673,"sku":"F1007-20UL","price":149.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577588228441,"sku":"F1007-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577588261209,"sku":"F1007-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F1007-IHC1.jpg?v=1773599184","url":"https:\/\/absource.de\/products\/pck2-antibody-sc-f1007","provider":"Absource Diagnostics","version":"1.0","type":"link"}